BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19465952)

  • 1. Cyclic ectopic Cushing's syndrome and somatostatin analogue treatment.
    Falhammar H
    N Z Med J; 2009 Apr; 122(1294):92-5. PubMed ID: 19465952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabergoline plus lanreotide for ectopic Cushing's syndrome.
    Pivonello R; Ferone D; Lamberts SW; Colao A
    N Engl J Med; 2005 Jun; 352(23):2457-8. PubMed ID: 15944436
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin).
    Hearn PR; Reynolds CL; Johansen K; Woodhouse NJ
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):181-5. PubMed ID: 2844445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic Cushing's syndrome: Paradoxical effect of somatostatin analogs.
    Biagetti B; Simó-Servat O; Ortiz-Z A; Iglesias C; Mesa J
    Endocrinol Diabetes Nutr; 2017 May; 64(5):276-278. PubMed ID: 29056252
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma.
    Rieu M; Rosilio M; Richard A; Vannetzel JM; Kuhn JM
    Horm Res; 1993; 39(5-6):207-12. PubMed ID: 8314205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of somatostatin analogue SMS 201-995 to control Cushing's syndrome due to ectopic release of ACTH from a bronchial carcinoid.
    Burrell L; Gray CE; Thomson JA
    Scott Med J; 1989 Oct; 34(5):533-4. PubMed ID: 2555918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for somatostatin and its analogs in Cushing's syndrome?
    de Herder WW; Lamberts SW
    Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.
    Ruszniewski P; Girard F; Benamouzig R; Mignon M; Bonfils S
    Gut; 1988 Jun; 29(6):838-42. PubMed ID: 2898423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchopulmonary carcinoid presenting as dexamethasone suppressible Cushing's syndrome.
    Sofka S; Jackson T
    W V Med J; 2013; 109(1):26-8. PubMed ID: 23413545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic Cushing's syndrome and small cell bronchial carcinoma].
    Mennecier B; Moreau L; Goichot B; Pauli G; Quoix E
    Rev Pneumol Clin; 1999 Apr; 55(2):77-80. PubMed ID: 10418050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic Cushing's syndrome in a young female with atypical [corrected] bronchial carcinoid tumour.
    Loh KC; Yap WM; Chia FK
    Singapore Med J; 1997 Jan; 38(1):29-31. PubMed ID: 9269352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome.
    Nomura C; Nakano Y; Tanaka T; Shima KR; Kometani M; Kanamori T; Ikeda H; Takeshita Y; Yoneda T; Takamura T
    Intern Med; 2022 Dec; 61(24):3693-3698. PubMed ID: 35650126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual vignette. Cushing's syndrome due to ectopic production of ACTH by a bronchial carcinoid.
    Szymajda A; Eledrisi MS; Lieberman S; Belalcazar LM; Schnadig V
    Endocr Pract; 2001; 7(6):492. PubMed ID: 11770489
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential indications for somatostatin analogs in Cushing's syndrome.
    Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
    J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer.
    Suyama K; Naito Y; Yoh K; Niho S; Goto K; Ohmatsu H; Nishiwaki Y; Ohe Y
    Intern Med; 2011; 50(4):335-8. PubMed ID: 21325767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndrome.
    Noorlander I; Elte JW; Manintveld OC; Tournoy KG; Praet MM; van Meerbeeck JP; Aerts JG
    Lung Cancer; 2006 Feb; 51(2):251-5. PubMed ID: 16352372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and its Analogs.
    Sun L; Coy DH
    Curr Drug Targets; 2016; 17(5):529-37. PubMed ID: 26951062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin analogue treatment of neuroendocrine tumours.
    de Herder WW; van der Lely AJ; Lamberts SW
    Postgrad Med J; 1996 Jul; 72(849):403-8. PubMed ID: 8935599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of a patient with bronchial carcinoid tumour and late presentation of Cushing's syndrome.
    Lim SC; Lim HS; Tan CE; Wong ZW; Fong CM
    Ann Acad Med Singap; 1998 Mar; 27(2):272-6. PubMed ID: 9663325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.